Ibrutinib treatment and egfr-mutant lung adenocarcinoma

Katerina Shulman, Olga Kazarin, Elias Tannous, Orit Sofer

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)385-386
Number of pages2
JournalIsrael Medical Association Journal
Issue number7
StatePublished - 1 Jun 2021
Externally publishedYes


  • Adenocarcinoma
  • Epithelial growth factor receptor (EGFR)
  • Ibrutinib
  • Lung

ASJC Scopus subject areas

  • General Medicine

Cite this